Jove M, Brana I, Oliva M, Hernando-Calvo A, et al. Phase I Trial of Intravenous VCN-01 Oncolytic Adenovirus and Durvalumab in Patients with Head and Neck Metastatic Squamous Cell Carcinoma Refractory to Immunotherapy. Clin Cancer Res 2026;32:3786-3798.
PMID: 42257887